BIO-Save offers innovative content and qualifications to:

  • Higher education institutions
  • Students, researchers and professionals
  • Biotech companies and SMEs
  • Non-governmental organisations
  • Business stakeholders

Active in:

  • Healthcare
  • Food and agricultural sectors
  • Pharmaceutical industry
  • Environmental industry
  • Biotech business

To its partners and the trainers in higher education, the BIO-Save offers:

  • International strategy and biotech profiling in respect to modern biotechnologies for climate change mitigation.
  • Upgraded leadership, delivery, entrepreneurship and mentoring skills.
  • Better positioning of partners locally and at European level for audience development (both in training and research).
  • An active network of biotech SMEs and enterprises and universities for accreditation and validation of the BIO-Save innovative programme.
  • Reshaped HE curricula to answer the Industry 4.0 needs
  • Digital resources to stimulate the interest of the students and trainers.
  • Updated innovative educational modules to provide novel knowledge and experience on approaches for climate change mitigation.
  • Involvement of the target audience into the BIO-Save educational offers.

To its associated partners, the BIO-Save offers:

  • Stronger awareness of the collaboration between the academia and the business.
  • Upgraded innovative biotech programmes for climate protection.
  • Increased networking opportunities.

To biotech practitioners and their organisations, the BIO-Save offers:

  • Advanced strategic thinking toward innovations in biotech for climate protection.
  • Experience in entrepreneurship, mentoring and coaching skills by working closely with students.
  • Improved business profile on the global market and the best possible trainees’ experience and efficient investment in staff time and facilities.
  • Access to relevant resources, incl. digital and case studies within the sector.

To post-graduate students, the BIO-Save offers:

  • Awareness of the real needs of the biotech sector.
  • Improved entrepreneurship thinking and soft skills.
  • Increased employment prospects.
  • Enhanced opportunities on the global biotech market.

Human capital is the key to growth.